Mevox
MEVOX develops optimized protein vaccines using structure-based antigen design and atomic-level antigen characterization. The company applies structural and computational methods to produce conformationally precise immunogens intended to increase neutralizing antibody responses, and works with external partners and domain experts on clinical development, CMC, regulatory strategy and access considerations.
Industries
Health Care
Medical
Pharmaceutical
Pharmaceutical Manufacturing
Nr. of Employees
small (1-50)
Expertise Areas
- Structure-based vaccine design
- Protein subunit vaccine development
- Antigen characterization and structural biology
- Bioprocess development and CMC
Key Technologies
- Structure-based antigen design
- Protein engineering
- High-resolution molecular/atomic characterization (structural biology)
- Bioinformatics and computational antigen design